T-Lymphocyte Homing: An Underappreciated yet Critical Hurdle for Successful Cancer Immunotherapy

Advances in cancer immunotherapy have offered new hope for patients with metastatic disease. This unfolding success story has been exemplified by a growing arsenal of novel immunotherapeutics, including blocking antibodies targeting immune checkpoint pathways, cancer vaccines, and adoptive cell ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Sackstein, Robert, Schatton, Tobias, Barthel, Steven R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446300/
https://www.ncbi.nlm.nih.gov/pubmed/28346400
http://dx.doi.org/10.1038/labinvest.2017.25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446300/
https://www.ncbi.nlm.nih.gov/pubmed/28346400
http://dx.doi.org/10.1038/labinvest.2017.25

Ejemplares similares